🧪
hypothesis

SIRT3 loss creates a mitochondrial acetylation-stress loop that weakens antioxidant and permeability control

Hypothesis

SIRT3 loss creates a mitochondrial acetylation-stress loop that weakens antioxidant and permeability control

Declining SIRT3 activity leaves SOD2, IDH2, and permeability-transition regulators hyperacetylated, reducing mitochondrial antioxidant capacity, NADPH support, and resistance to pore opening.
🧬 SIRT3; SOD2; IDH2; PPIF🩺 neurodegeneration🎯 Composite 56%💱 $0.54▼4.7%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.63 (15%) Evidence 0.58 (15%) Novelty 0.66 (12%) Feasibility 0.47 (12%) Impact 0.61 (12%) Druggability 0.42 (10%) Safety 0.62 (8%) Competition 0.49 (6%) Data Avail. 0.55 (5%) Reproducible 0.57 (5%) KG Connect 0.50 (8%) 0.560 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite56%

🧪 Overview

Declining SIRT3 activity leaves SOD2, IDH2, and permeability-transition regulators hyperacetylated, reducing mitochondrial antioxidant capacity, NADPH support, and resistance to pore opening. Increased ROS and energetic failure can then further suppress NAD+-dependent SIRT3 function, forming a secondary resilience-collapse loop. This is biologically coherent but currently the least direct and least well-validated self-amplifying mechanism.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["NAD+ in Mitochondria<br/>Metabolic State Signal"]
    B["SIRT3 Activation<br/>Mitochondrial Deacetylase"]
    C["IDH2 Deacetylation<br/>TCA Cycle Enhanced"]
    D["SOD2 Deacetylation<br/>K68/K122 Activation"]
    E["Complex I/III Deacetylation<br/>OXPHOS Efficiency"]
    F["ROS Reduction<br/>Oxidative Stress Attenuated"]
    G["SIRT3 Reduced in Aging/AD<br/>Mitochondrial Hyperacetylation"]
    H["Mitochondrial Dysfunction<br/>Bioenergetic Failure"]
    A --> B
    B --> C
    B --> D
    B --> E
    C --> F
    D --> F
    E --> F
    G -.->|"reduces"| B
    G --> H
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style F fill:#1b5e20,stroke:#81c784,color:#81c784
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
SIRT3 declines in aged brain and PD models, and knockout increases toxin vulnerability.
PMID:25302784
Supports
SIRT3 overexpression protects dopaminergic neurons via SOD2 activation.
PMID:25943887
Supports
Honokiol showed SIRT3-linked benefit in a PD model.
PMID:29914931
Contradicts
Apparent benefit from proposed activators may reflect off-target mitochondrial or anti-inflammatory effects rather than SIRT3-specific loop control.
PMID:29914931
Contradicts
The source paper supports multifactorial oxidative death signaling, making SIRT3 more likely a modifier than a dominant engine.
PMID:40712453
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — SIRT3;

No curated PDB or AlphaFold mapping for SIRT3; yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for SIRT3; SOD2; IDH2; PPIF from GTEx v10.

Cerebellar Hemisphere22.1 Cerebellum22.0 Cortex19.8 Nucleus accumbens basal ganglia19.4 Frontal Cortex BA918.9 Caudate basal ganglia16.4 Anterior cingulate cortex BA2414.6 Putamen basal ganglia13.4 Hypothalamus12.7 Amygdala10.9 Hippocampus10.3 Substantia nigra10.0 Spinal cord cervical c-18.8median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for SIRT3; SOD2; IDH2; PPIF →

No DepMap CRISPR Chronos data found for SIRT3; SOD2; IDH2; PPIF.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.3%
Volatility
Low
0.0093
Events (7d)
2
Price History
▼4.7%

💾 Resource Usage

LLM Tokens
13,113
$0.0393
Total Cost
$0.0393

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF NAD+ levels are experimentally reduced by 50% using FK866 (NAMPT inhibitor) in Sirt3+/+ neurons, THEN SIRT3 activity will decrease (>40% reduction in deacetylation of SOD2), mitochondrial ROS will NAD+ depletion will synergize with SIRT3 loss to produce accelerated mitochondrial dysfunction, confirming the self-amplifying resilience-collapse loop; combine— no observation —pending0.35
IF SIRT3 is genetically deleted in primary neurons (Sirt3 knockout or CRISPR knockout in iPSC-derived neurons), THEN hyperacetylation of SOD2 (Lys122), IDH2 (Lys83), and PPIF (Lys148) will increase wiHyperacetylation of SIRT3 target proteins will precede and correlate with functional deficits in antioxidant capacity and mitochondrial permeability resistance,— no observation —pending0.45
🔮 Falsifiable Predictions (2)
pendingconf 45%
IF SIRT3 is genetically deleted in primary neurons (Sirt3 knockout or CRISPR knockout in iPSC-derived neurons), THEN hyperacetylation of SOD2 (Lys122), IDH2 (Lys83), and PPIF (Lys148) will increase within 24-48 hours, followed by measurable decreases in SOD2 activity (>30% reduction via lucigenin ch
Predicted outcome: Hyperacetylation of SIRT3 target proteins will precede and correlate with functional deficits in antioxidant capacity and mitochondrial permeability r
Falsification: Hyperacetylation occurs without corresponding functional changes in SOD2 activity, NADPH levels, or mitochondrial permeability; OR functional deficits occur in the absence of increased acetylation at
pendingconf 35%
IF NAD+ levels are experimentally reduced by 50% using FK866 (NAMPT inhibitor) in Sirt3+/+ neurons, THEN SIRT3 activity will decrease (>40% reduction in deacetylation of SOD2), mitochondrial ROS will increase (>50% via MitoSOX fluorescence), and mitochondrial membrane potential will collapse (>30% Δ
Predicted outcome: NAD+ depletion will synergize with SIRT3 loss to produce accelerated mitochondrial dysfunction, confirming the self-amplifying resilience-collapse loo
Falsification: NAD+ reduction produces similar mitochondrial dysfunction regardless of SIRT3 status; OR SIRT3 knockout produces equivalent dysfunction regardless of NAD+ levels; OR the loop does not accelerate beyon
View on SciDEX ↗